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Abstract
Background: Both double-balloon enteroscopy (DBE) and video capsule endoscopy (VCE) have similar diagnostic
yields for patients with overt obscure gastrointestinal bleeding (OGIB). However, the choice of initial modality is still
controversial. The aim of this study was to show the clinical outcome of the strategy of initial VCE, followed by DBE.
Methods: Eighty-nine consecutive overt OGIB patients who had undergone VCE as the initial examination were
analyzed. The interpreters of VCE evaluated the necessity of performing DBE, and the antegrade or retrograde route
was chosen, depending on the transit time of the capsule.
Results: Thirty-seven patients (42 %) underwent DBE depending on the findings of VCE. Of these, bleeding sites in
the small bowel were identified in 29 patients with the initially selected route (21 antegrade and 8 retrograde). The
remaining 8 later underwent DBE by the other route, but 7 had no bleeding lesion, which was confirmed by
second-look VCE. One remaining patient had a jejunal varix found by VCE, but DBE from either side could not reach
the lesion. The sensitivity and negative predictive value of VCE were 100 %, both for the presence of small bowel
lesions and the requirement of hemostasis in the small bowel; this indicated that VCE never misses relevant findings in
the small bowel, and that negative VCE findings correspond to the lack of necessity for further examination.
Conclusions: VCE as the initial examination can efficiently identify overt OGIB patients who require DBE. The strategy
of initial VCE for overt OGIB appears to be reasonable.
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Background
Obscure gastrointestinal bleeding (OGIB) is defined by
the American Gastroenterological Association as bleed-
ing of unknown cause after upper or lower endoscopy
[1]. OGIB can be further classified into occult and overt
bleeding. Occult OGIB is defined as iron deficiency
anemia, with or without a positive fecal occult blood
test, while overt OGIB indicates clinically perceptible
bleeding that recurs or persists despite negative initial
endoscopic and radiologic evaluations. In overt OGIB,
therefore, immediate identification of the bleeding lesion
is needed for appropriate therapy, including hemostatic
treatment to rescue unstable patients. However, the
diagnostic performance and accuracy of conventional
diagnostic strategies, including small intestinal radiog-
raphy, abdominal computed tomography, magnetic
resonance imaging, digital subtraction angiography,
radionuclide scanning, and intraoperative endoscopy,
have not been satisfactory for detecting small intestine
diseases [2, 3].
Since the introduction of video capsule endoscopy
(VCE) [4] and double-balloon enteroscopy (DBE) [5] in
2000 and 2001, respectively, these modalities have en-
abled direct observation of the lumen of the small intes-
tine. VCE is a new type of endoscopy, which allows
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painless endoscopic imaging of the entire small bowel,
and is well tolerated by patients [6]. However, lack of
therapeutic capability, including hemostasis, is a critical
drawback of the device. On the other hand, DBE is a
new insertion method for enteroscopy, which enables
endoscopic scrutiny of the entire small intestine, and
endoscopic intervention, such as polypectomy, hemostasis,
and sampling of tissue. Total enteroscopy may be achieved
through a combination of antegrade and retrograde ap-
proaches [7]. However, it is an invasive procedure, and it
typically requires patient sedation, two endoscopists, and
additional medical staff.
Both VCE and DBE reportedly demonstrate similarly
high diagnostic yields of small intestinal disorders [8, 9].
However, in the clinical situation of overt OGIB, the role
of these new modalities has not been fully established. In
particular, the choice of initial modality is still controver-
sial. The policy of some endoscopists is that DBE by the
antegrade route should be the initial procedure for overt
OGIB, because the intestinal lesions causing overt OGIB
are most likely localized in the proximal part of the
small bowel [10]. Others advocate that VCE should be
the initial choice because it is noninvasive and is capable
of visualizing the entire small intestine. Recently pub-
lished guidelines in Europe recommended VCE as the
initial examination for overt OGIB, mainly due to its
safety [11]. However, the validation of this strategy is
incomplete.
Our recent policy for overt OGIB is also initial VCE,
followed by DBE via the antegrade or retrograde route,
as appropriate. Hence, consecutive patients with overt
OGIB underwent VCE as the initial examination for
small bowel lesions in our hospital. In this study, the
clinical outcome of these patients is shown, and the
strategy of initial VCE for overt OGIB is validated.
Methods
Patients
This is a retrospective analysis of overt OGIB patients
who had visited Wakayama Medical University Hospital
between December 2008 and December 2014. During
this period, 89 consecutive patients had undergone VCE
as the initial examination for the bleeding site in the
small intestine. All patients had ongoing or recent overt
gastrointestinal (GI) bleeding, and had undergone upper
endoscopy and colonoscopy with negative results. The
ongoing bleeding was defined as visible melena at the
time of first consultation to our institution. The
remaining subjects were regarded as having previous
OGIB. Some patients underwent upper endoscopy and/
or colonoscopy at another institution.
The retrospective analysis was approved by the institu-
tional review board of Wakayama Medical University.
Written informed consent was obtained from each
patient.
VCE procedure
Patients were examined using PilCam SB® (SB1, SB2, or
SB3) (Covidien, Irvine, CA, USA). The video capsule
was swallowed after preparation with 50 g of magnesium
citrate. The digital information recorded was down-
loaded into a computer, and the images were analyzed
using the proprietary RAPID software (Covidien) by two
experienced reviewers independently. When the diagno-
sis differed between the two reviewers, they conferred
until they reached a consensus. The transit time through
the entire small intestine was recorded. In addition, if
the bleeding site was detected, the time when the cap-
sule reached the site was also recorded.
DBE procedure
The indication for DBE was determined by the VCE re-
viewers depending on the findings. If a suspected cause
of bleeding, such as a polypoid lesion, open ulcer, vascu-
lar lesion, Dieulafoy’s lesion, or hemorrhagic erosion was
detected by VCE, DBE was indicated. DBE was per-
formed using an enteroscope for small bowel observa-
tion (EN-450 T5/W or EN-580 T, Fujinon Inc., Saitama,
Japan), using the FUJIFILM high-resolution enteroscopy
system.
The antegrade or retrograde insertion route was
chosen according to the transit time of the VCE. If the
suspected bleeding site was detected at a time point be-
fore one-half of the transit time through the small intes-
tine, DBE was inserted orally. Alternatively, the device
was inserted by the retrograde route. DBE was inserted
with no further bowel preparation after VCE.
Statistical analysis
Statistical analysis was conducted using the STATA pro-
gram (version 13, Stata Corp., TX, USA). Sensitivity,
specificity, positive predictive value (PPV), negative pre-
dictive value (NPV), and accuracy were determined with
95 % confidence intervals (CIs).
Results
Patient course and VCE results
During the study period, 89 patients with overt OGIB
underwent VCE as the initial examination for the small
intestine, and a record of the entire small intestine was
obtained in all of the patients. The clinical data for these
patients are shown in Table 1. Fifty-five (62 %) patients
had ongoing bleeding, while the remaining 34 (38 %)
had a recent history of overt bleeding. Medications associ-
ated with bleeding, including antiplatelet agents, anticoag-
ulants, and/or nonsteroidal anti-inflammatory drugs, were
used by 31 (35 %) patients. The drugs had been taken just
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before starting VCE in all patients. Because DBE was done
within almost 24 hours after VCE, those drugs seemed to
be active even during DBE.
The clinical course of these patients is shown in Fig. 1.
Bleeding in the small intestine could be observed in 58
(55 %) subjects with VCE. Bleeding from the GI tract at
a site other than the small intestine, including gastric an-
tral vascular ectasia, duodenal ulcer, and diverticulum of
the colon, was detected in 22 (25 %). These 22 patients
were later reexamined with upper endoscopy or colonos-
copy, and the other bleeding site was confirmed. The
remaining 9 patients had negative findings in the small
bowel as well as in other GI segments with VCE, and the
bleeding sites of these patients could not be elucidated
during follow-up.
Of 58 patients with positive findings in the small
bowel, 21 were not considered for DBE, because they
had tiny erosive lesions (13), a submucosal-type lipoma
(4), a single ulcer in a healing stage (2), radiation enter-
itis (1), or intestinal Behçet’s disease (1). Of these, 20 pa-
tients, except one with intestinal Behçet’s disease,
Fig. 1 Flow chart of the study subjects
Table 1 Clinical characteristics of study patients
Characteristic Patients n = 89
Age, years, median (range) 70 (30–92)
Male : Female 48 : 41
Type of gastrointestinal bleeding
Overt ongoing 55 (62 %)
Overt previous 34 (38 %)
Medication used
Antiplatelet medicine 16 (18 %)
Anticoagulation 9 (10 %)
Both anticoagulation and antiplatelet 3 (3 %)
NSAIDs 3 (3 %)
Hemoglobin, g/L, median (range) 9.3 (5.3–14.7)
NSAIDs, Non-steroidal anti-inflammatory drugs
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required no further examination or intervention during
follow-up. The Behçet’s disease patient had episodes of
melena three times prior to examination by VCE, which
revealed several punched-out ulcers in the small intes-
tine. However, intestinal perforation requiring emer-
gency enterectomy occurred in this patient, just after the
VCE procedure, and before determination of the indica-
tion for DBE. Although the causal relationship between
perforation in this patient and VCE procedure was un-
certain, the event may be considered as the complication
of VCE. Accordingly, the remaining 37 patients under-
went DBE.
Choice of route and the findings of DBE
Antegrade or retrograde choice of route for DBE was de-
termined according to the recorded time to the bleeding
site, as shown in the Methods section, resulting in 26
using the antegrade route and 11 the retrograde route.
The bleeding lesions were found in 21 of 26 patients
with the antegrade route, and hemostatic treatment was
performed in 13. On the other hand, bleeding lesions
were detected in 8 of 11 patients who had undergone
DBE with the retrograde route, and hemostatic treat-
ment was performed in 5. Figure 2 shows representative
images of VCE and DBE of a patient with Dieulafoy
lesion.
Bleeding lesions could not be identified by initial DBE
with the antegrade route in 5 patients and in 3 patients
with the retrograde route. All patients subsequently
underwent DBE with the alternate route. However, the
bleeding sites could not be found in any of these
patients. One patient with type C liver cirrhosis was di-
agnosed with a jejunal varix with VCE. Antegrade DBE
was initially carried out, but could not reach the varix
because of adhesions after splenectomy. A retrograde
approach for this patient then also failed to reach the le-
sion. For the remaining 7 patients, VCE was performed
again three months later, but none showed positive find-
ings in the small intestine.
Diagnostic performance of VCE
The sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV), and accuracy of
VCE, for the detection of both the bleeding site in the
small intestine and the lesion requiring hemostasis, with
the findings on DBE defined as the gold standard, are
shown in Table 2. The performance of VCE was particu-
larly good, with 100 % sensitivity and NPV in detection
of both the bleeding site and lesions requiring
hemostasis.
The comparison of the diagnoses between VCE and
DBE in 37 patients is shown in Table 3. The diagnosis of
3 AVMs and 2 GISTs were confirmed by surgical spe-
cimens. Polyps revealed to be 2 lipomas and 1
hemangioma with reference to the resected specimens
with endoscopic mucosal resection. VCE misdiagnosed 8
patients, based on a diagnosis with DBE. The diagnoses
with DBE in 3 patients who had been regarded as having
a Dieulafoy’s lesion with VCE, were diverticulum of the
colon, diverticulum of the jejunum, and ulcer scarring.
No significant findings were observed with DBE in 4 pa-
tients diagnosed as an erosion and 1 diagnosed as an
ulcer.
Discussion
Recent meta-analysis of examinations for small bowel le-
sions reported that both VCE and DBE have similarly
high diagnostic yields [9]. However, the choice of modal-
ity for use in overt OGIB has not yet been clearly estab-
lished. In particular, the choice of the initial approach is
controversial. Recommendation of initial VCE by the
European Society of Gastrointestinal Endoscopy is based
Fig. 2 A case of overt ongoing OGIB. a VCE showed spurting
bleeding from Dieulafoy lesion (arrow). b DBE was inserted perorally
according to the transit time of VCE, and the bleeding point could
be detected easily (circle). c, d Hemostasis was performed with argon
plasma coagulation
Table 2 Diagnostic performance of VCE for small intestine
lesions and for lesions requiring hemostasis
For small intestine disease For lesions needed
hemostasis
Sensitivity (%) (95 % CI) 100 (94.5–100) 100 (87.2–100)
Specificity (%) (95 % CI) 85.4 (78.9–85.4) 77.6 (73.4–77.6)
PPV (%) (95 % CI) 88.9 (84.0–88.9) 59.5 (51.8–59.5)
NPV (%) (95 % CI) 100 (92.4–100) 100 (94.6–100)
Accuracy (%) (95 % CI) 93.3 (87.3–93.3) 83.1 (76.8–83.1)
PPV positive predictive value, NPV negative predictive value, CI
confidence interval
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only on the excellent safety profile of VCE, [11] and the
validation of the superiority of the strategy is incomplete.
On this background, we demonstrated the results of
our clinical experience for overt OGIB. Our policy for
overt OGIB was to perform VCE initially, followed by
DBE as necessary. Our results have the following clinic-
ally relevant implications. First, an initial VCE procedure
could precisely determine the necessity of subsequent
DBE, except one case with perforation with obscure
causal relationship with VCE. In fact, the sensitivity and
NPV of VCE were 100 %, both for the presence of small
bowel lesions and the requirement of hemostasis in the
small bowel. These perfect results indicate that VCE
never misses relevant findings in the small bowel, and
that negative VCE findings correspond to the lack of ne-
cessity for further examination. Because missed overt
OGIB may lead to critical clinical outcomes, VCE as the
initial examination for OGIB appears to be optimal.
In this context, it is surprising that approximately
60 % of patients who had undergone VCE could dis-
pense with DBE, suggesting that the strategy of initial
VCE would greatly reduce the effort, burden, and cost
of further examinations, including DBE. In particular,
VCE for overt OGIB revealed that 25 % had bleeding
sites outside the small bowel, but within the reach of
upper endoscopy or colonoscopy, and that 10 % had
no bleeding site throughout the intestine. The rate of
presence of bleeding sites outside of the small intes-
tine appears to be large. In fact, previous reports
demonstrated that the rates ranged 12.5–28 % [12].
However, because the detection rate of small bowel
lesions by VCE in our study was equivalent to that of
previous reports (65 % vs. 59.4–72.5 %), [13–15] our
population does not appear to be skewed by inappro-
priate upper GI endoscopy or colonoscopy [16]. Fur-
ther investigation should be performed on this issue.
As the second relevant finding of our study, VCE
could determine the appropriate insertion route for
DBE. Although DBE enables endoscopic interventions
including hemostasis, observation of the entire small in-
testine usually requires both antegrade and retrograde
insertions. Because the procedure is cumbersome and
requires much time and medical staffing, a predeter-
mined appropriate insertion route for bleeding lesions
would reduce the burdens on patients, endoscopists, and
medical staff. Hence, VCE as the initial study, followed-
by DBE, appears to be the best strategy for overt OGIB.
Li et al. suggested the ability of VCE to guide the
choice of insertion route of DBE [17]. Similar to our
strategy, the authors also determined the insertion route
by the time point at which VCE reached the target lesion.
While our point of divergence for antegrade vs. retrograde
insertion was 0.5, their criterion was 0.6, (i.e., if VCE
reached the target at a time 60 % or less than the total
small bowel transit time, DBE was inserted by the ante-
grade route). The result for reaching the target lesion with
the initial DBE procedure was 100 % in their study, as well
as in ours, although the indication for DBE in their study
was not confined to overt OGIB. If the divergence criter-
ion of 0.6 had been adopted in our study, 2 patients who
underwent retrograde DBE would have qualified for the
antegrade DBE route (the indices were 0.51 and 0.58, re-
spectively). Naturally, there may be subjects with lesions
in the mid-portion of the small bowel, which DBE by ei-
ther route could reach. The optimal method for choice of
route for these patients should be investigated further.
Our study has limitations. First, the study design is
retrospective, and the results of the single-arm strategy
(initial VCE) alone were shown. Our strategy for overt
OGIB, i.e., initial VCE followed by DBE, seems to be
fully validated by our clinical experience, despite the
drawback of the small number of the analyzed patients.
For more precise evaluation of our strategy, however,
studies with larger number of patients from multiple in-
stitutes and/or a prospective controlled study comparing
DBE with and without prior VCE should be performed.
However, such a study appears to be too risky because
the effectiveness of prior VCE was obvious, and overt
OGIB is sometimes fatal. Second, not all patients under-
went prior upper or lower endoscopy in our hospital.
Therefore, there may have been misdiagnoses of overt
OGIB in our patients.
Conclusion
In conclusion, a considerable proportion of overt OGIB
patients do not require intervention including
hemostasis, and can therefore avoid further invasive and
costly procedures, such as DBE. The strategy of initial
VCE for overt OGIB patients can efficiently identify pa-
tients who require DBE as the subsequent examination.
Table 3 Consistency of the findings between VCE and DBE
VCE findings Diagnosis with DBE







Jejunum varix 2 1d
AVM, Arteriovenous malformation ; GIST, Gastrointestinal stromal tumor
a, The diagnoses of 3 patients were diverticulum of the jejunum, diverticulum
of the colon, and ulcer scarring
b, No significant findings were observed with DBE in 4 patients
c, No significant findings were observed with DBE in one patient
d, Jejunal varix was suspected in one patient, but DBE failed because
of adhesions
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Hence, the strategy is recommended, not only because
of the safety of VCE, but also for better clinical out-
comes for these patients.
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